Literature DB >> 27565712

Importance of membrane-proximal N-glycosylation on integrin β1 in its activation and complex formation.

Sicong Hou1, Qinglei Hang1, Tomoya Isaji1, Jishun Lu1, Tomohiko Fukuda1, Jianguo Gu2.   

Abstract

N-Glycosylation of integrin α5β1 plays important roles in cell biologic functions; however, the mechanisms that underlie those roles remain poorly understood. Here, we present evidence that the membrane-proximal N-glycosylation on integrin β1 could positively regulate cell migration by promoting β1 activation. The S4-6 β1 mutant contains only 3 N-glycosylation sites, which are essential for α5 and β1 heterodimer formation, and despite only a small difference in expression levels of α5β1 between wild-type and S4-6 mutant, cell spreading and migration of the S4-6 mutant was significantly decreased compared with that of control. Consistent with these phenotypes, β1-mediated cellular signaling and its activation were clearly suppressed in the S4-6 mutant. Of note, these developments could be rescued by restoration of N-glycosylation sites in the membrane-proximal domain. Further study on the regulatory mechanisms suggested that membrane-proximal N-glycosylation is critical for intermolecular interactions between integrin β1 and other cell membrane proteins, such as syndecan-4 and epidermal growth factor receptor. Moreover, α2,6-sialylation is required for β1 activation. These data suggest a novel regulatory mechanism wherein N-glycosylation near the cell membrane on β1 may serve as a platform that facilitates its complex formation on the cell membrane, thereby affecting integrin-mediated functions.-Hou, S., Hang, Q., Isaji, T., Lu, J., Fukuda, T., Gu, J. Importance of membrane-proximal N-glycosylation on integrin β1 in its activation and complex formation. © FASEB.

Entities:  

Keywords:  cell migration; cell signaling; sialylation

Mesh:

Substances:

Year:  2016        PMID: 27565712     DOI: 10.1096/fj.201600665R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.

Authors:  Colleen M Britain; Kaitlyn A Dorsett; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

2.  Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.

Authors:  Sicong Hou; Weiguo Jin; Weiming Xiao; Bin Deng; Dacheng Wu; Jiehua Zhi; Keyan Wu; Xiaowei Cao; Shuai Chen; Yanbing Ding; Hongcan Shi
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

3.  A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for N-glycan sialylation in cancer cells.

Authors:  Tomoya Isaji; Sanghun Im; Akihiko Kameyama; Yuqin Wang; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

4.  Glycoengineering human neural stem cells (hNSCs) for adhesion improvement using a novel thiol-modified N-acetylmannosamine (ManNAc) analog.

Authors:  Jian Du; Xiao Liu; Kevin J Yarema; Xiaofeng Jia
Journal:  Biomater Adv       Date:  2022-01-21

5.  ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.

Authors:  Asmi Chakraborty; Kaitlyn A Dorsett; Hoa Q Trummell; Eddy S Yang; Patsy G Oliver; James A Bonner; Donald J Buchsbaum; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

6.  The importance of N-glycosylation on β3 integrin ligand binding and conformational regulation.

Authors:  Xiulei Cai; Aye Myat Myat Thinn; Zhengli Wang; Hu Shan; Jieqing Zhu
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

7.  N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin β1 and promotes HCC metastasis.

Authors:  Jian Cui; Wan Huang; Bo Wu; Jin Jin; Lin Jing; Wen-Pu Shi; Zhen-Yu Liu; Lin Yuan; Dan Luo; Ling Li; Zhi-Nan Chen; Jian-Li Jiang
Journal:  J Pathol       Date:  2018-03-30       Impact factor: 7.996

8.  Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling.

Authors:  Lanming Cheng; Lin Cao; Yurong Wu; Wenjie Xie; Jiaqi Li; Feng Guan; Zengqi Tan
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

9.  A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.

Authors:  Sok-Hyong Lee; Fatima Khwaja Rehman; Kari C Tyler; Bing Yu; Zhaobin Zhang; Satoru Osuka; Abdessamad Zerrouqi; Milota Kaluzova; Costas G Hadjipanayis; Richard D Cummings; Jeffrey J Olson; Narra S Devi; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2020-01-22       Impact factor: 12.531

Review 10.  Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators.

Authors:  Alessandra Tolomelli; Paola Galletti; Monica Baiula; Daria Giacomini
Journal:  Cancers (Basel)       Date:  2017-07-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.